Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T22:23:54.605Z.
Calculation as of: 2026-10-06T22:23:54.605Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c6190991d8493eebdba731817b981db063e7ae28b86b69413d904cae69ffb2ef
EARNINGS YIELD
N/A
Market Cap
$48.76M
Earnings Yield
N/A
TTM Avg
14.92%
3Y Avg
14.92%
5Y Avg
14.92%
Market Cap
$48.89M
Earnings Yield
N/A
TTM Avg
6.48%
3Y Avg
10.69%
5Y Avg
10.63%
Market Cap
$49.25M
Earnings Yield
N/A
TTM Avg
2.32%
3Y Avg
1.59%
5Y Avg
1.59%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TELA Bio, Inc. (TELA) | $48.77M | N/A | N/A | N/A | N/A |
| Microbot Medical Inc. (MBOT)vs › | $48.76M | N/A | 14.92% | 14.92% | 14.92% |
| Sensus Healthcare, Inc. (SRTS)vs › | $48.89M | N/A | 6.48% | 10.69% | 10.63% |
| Apollomics, Inc. (APLM)vs › | $48.53M | N/A | N/A | N/A | N/A |
| Precision Optics Corporation, Inc. (POCI)vs › | $49.25M | N/A | 2.32% | 1.59% | 1.59% |
| Clene Inc. (CLNN)vs › | $49.45M | N/A | 8.45% | 8.45% | 8.45% |
| Lite Strategy, Inc. (LITS)vs › | $47.98M | N/A | N/A | N/A | N/A |
| INmune Bio, Inc. (INMB)vs › | $49.71M | N/A | N/A | N/A | N/A |
| Envoy Medical, Inc. (COCH)vs › | $50.27M | N/A | 0.74% | 0.74% | 0.74% |
| biote Corp. (BTMD)vs › | $50.28M | 10.24% | 27.99% | 16.26% | 33.61% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
